Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers-Reference-Cited by-同舟云学术

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

Published:2022-02 Issue:1 Volume:7 Page:100336
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Palmeri M.,Mehnert J.,Silk A.W.,Jabbour S.K.,Ganesan S.,Popli P.,Riedlinger G.,Stephenson R.,de Meritens A.B.,Leiser A.,Mayer T.,Chan N.,Spencer K.,Girda E.,Malhotra J.,Chan T.,Subbiah V.,Groisberg R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden;Morrison;J Immunother Cancer,2018

2. First-line nivolumab plus ipilimumab in advanced non-small-cell lung cancer (CheckMate 568): outcomes by programmed death ligand 1 and tumor mutational burden as biomarkers;Ready;J Clin Oncol,2019

3. Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing;Rizvi;J Clin Oncol,2018

4. Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers;Goodman;Mol Cancer Ther,2017

5. Predicting outcomes in patients with advanced non-small cell lung cancer enrolled in early phase immunotherapy trials;Maymani;Lung Cancer,2018

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of ferroptosis-related lncRNAs for predicting prognosis and immunotherapy response in non-small cell lung cancer;Future Generation Computer Systems;2024-10

2. Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa;Cureus;2024-09-10

3. Cyclin B1: A potential prognostic and immunological biomarker in pan-cancer;Biomolecules and Biomedicine;2024-09-06

4. Epithelial cell-related prognostic risk model in breast cancer based on single-cell and bulk RNA sequencing;Heliyon;2024-09

5. FAT1 as a tumor mutation burden specific gene affects the immunotherapy effect in head and neck squamous cell cancer;Drug Resistance Updates;2024-09